|
MechanismGABAA receptor positive allosteric modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with AstraZeneca US
0 Patents (Medical) associated with AstraZeneca US
100 Deals associated with AstraZeneca US
100 Translational Medicine associated with AstraZeneca US